Sintx Technologies, Inc. SINT
1.56 USD -0.06 (-3.70%)
Nov 12, 2026, 11:02 AM EST
1.53 Day range 1.60
1.40 52-week range 4.46
- YTD
- -59.59%
- 1 year
- -54.52%
News
globenewswire.com SINTX Technologies Advances SiN/PEEK 3D Printing Platform Toward Personalized Orthopedic Implant Commercialization Company completes additive manufacturing facility buildout, advances proprietary silicon nitride–PEEK technology, expands leadership and targets initial product availability in 2027
seekingalpha.com Sintx Technologies, Inc. (SINT) Q3 2026 Earnings Call Prepared Remarks Transcript Sintx Technologies, Inc. ( SINT ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Kevin Ontiveros - Chief Legal Officer Eric Olson - CEO & Chairman of the Board Kevin Trask -…
benzinga.com SINTX Technologies Q3 2026 Earnings Call Transcript SINTX Technologies (NASDAQ:SINT) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
globenewswire.com SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device Commercialization Third quarter revenue increases more than tenfold year over year, while operating losses decrease 51% as Company advances commercialization of its proprietary silicon nitride technologies
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Anbio Biotechnology (NASDAQ:NNNN) stock moved upwards by 16.9% to $6.49 during Friday's after-market session. The market value of their outstanding shares is at $276.0 million. Stablecoin…
benzinga.com SINTX Reports Preliminary Q3 Revenue of $2.2M, Exceeding High End Of Company’s Previously Announced Guidance Of $0.9M-$1.1M Third-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales to Fortune 500 customers; Company reiterates Q4 revenue guidance Revenue milestone also enables…- benzinga.com Ascendiant Capital Maintains Buy on SINTX Technologies, Raises Price Target to $12.5 Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and raises the price target from $12 to $12.5.
benzinga.com SINTX Technologies Regains Nasdaq Compliance SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a company focused on advanced silicon nitride materials and medical technologies, today announced that it received written…
benzinga.com SINTX Technologies Q2 EPS $(0.75) Misses $(0.66) Estimate, Sales $452.000K Beat $406.667K Estimate SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.66) by 13.64 percent. This is a 17.58 percent increase over losses…
benzinga.com SINTX Technologies Receives Purchase Orders From Multiple Contract Manufacturing Customers With Aggregate Value Exceeding $3.2M For Production Of Advanced Ceramic Components SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material technologies, today announced that it has received purchase…
benzinga.com Maxim Group Reinstates Buy on SINTX Technologies, Announces $6 Price Target Maxim Group analyst Anthony Vendetti reinstates SINTX Technologies (NASDAQ:SINT) with a Buy and announces $6 price target.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com SINTX Technologies Announces $4.5M Private Placement, Issuing 1,882,845 Shares At $2.39 Combined Price With Warrants For 1,882,845 Class A And 1,882,845 Class B Shares Exercisable At $2.14 SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced biomaterials company focused on developing silicon nitride technologies for medical applications, today announced that…
benzinga.com Why SINTX Technologies Stock Is Trading Lower Today Shares of SINTX Technologies are trading lower Wednesday afternoon following the company's disclosure of a Nasdaq non-compliance notice.
benzinga.com Sintx Technologies Receives Nasdaq Noncompliance Notice, Gets Time Through July 6 To Regain Compliance https://www.sec.gov/ix?doc=/Archives/edgar/data/1269026/000149315226025377/form8-k.htm- benzinga.com HC Wainwright & Co. Reiterates Buy on SINTX Technologies, Maintains $10 Price Target HC Wainwright & Co. analyst Brandon Folkes reiterates SINTX Technologies (NASDAQ:SINT) with a Buy and maintains $10 price target.
- benzinga.com SINTX Technologies Q1 EPS $(0.70) Misses $(0.66) Estimate, Sales $380.000K Beat $300.000K Estimate SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.66) by 6.06 percent. This is a 45.74 percent increase over losses of…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com HC Wainwright & Co. Initiates Coverage On SINTX Technologies with Buy Rating, Announces Price Target of $10 HC Wainwright & Co. analyst Brandon Folkes initiates coverage on SINTX Technologies (NASDAQ:SINT) with a Buy rating and announces Price Target of $10.
- benzinga.com Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $12 Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and lowers the price target from $16 to $12.
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com SINTX Releases Corporate Update On Key Milestones, Including First Human Surgical Procedure Using FDA-Approved Foot & Ankle Osteotomy Wedge System Recent 2026 Milestones and Execution Progress::Completed first human implant of the SINAPTIC Foot & Ankle Osteotomy Wedge SystemAppointed Ryan Elmore as President to lead commercialization and…
benzinga.com SINTX Technologies Completes First-In-Human Surgical Procedure Utilizing FDA-Cleared SINAPTIC Foot & Ankle Osteotomy Wedge System Major clinical milestone marks SINTX's entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platformSALT LAKE CITY, Utah, March 19,…- benzinga.com Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $16 Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and lowers the price target from $25 to $16.
- benzinga.com SINTX Technologies Strikes Supply Agreement With Evonik To Produce Proprietary Silicon Nitride-PEEK Compound SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company, today announced that it has signed a supply agreement with Evonik Corporation…
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com SINTX Technologies Q3 EPS $(1.19) Misses $(0.51) Estimate, Sales $208.000K Miss $300.000K Estimate SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate of $(0.51) by 133.33 percent. This is a 82.9 percent increase over losses…
- benzinga.com SINTX Technologies Receives FDA 510(K) Clearance For Its SINAPTIC Foot & Ankle Osteotomy Wedge System SALT LAKE CITY, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on…
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com SINTX Technologies Announces FDA 510(K) Clearance For SINAPTIC Foot & Ankle Osteotomy Wedge System; SINTX Plans U.S. Commercial Launch In Q1 2026 FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT)…- benzinga.com SINTX Technologies Secures Patent for Antipathogenic Fabric Methods, Strengthening Infection-Resistant IP SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced that the United…
- benzinga.com SINTX Technologies Expands Patent Protections for Antipathogenic Fabrics, Strengthening Biomedical IP Portfolio SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced that the United…
- benzinga.com Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $25 Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and lowers the price target from $28 to $25.
- benzinga.com SINTX Raises $3.8M Through Warrant Exercise to Strengthen Working Capital SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced the entry into…
- benzinga.com SiNtx Technologies Appoints Kevin Trask As CFO https://www.sec.gov/ix?doc=/Archives/edgar/data/0001269026/000149315225012731/form8-k.htm
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket - benzinga.com Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
benzinga.com Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - benzinga.com Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- benzinga.com Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session